{
    "Trade/Device Name(s)": [
        "Quantimetrix Drug of Abuse Urine Screen Control"
    ],
    "Submitter Information": "Quantimetrix Corporation",
    "510(k) Number": "K060417",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "February 16, 2006",
    "Summary Letter Received Date": "February 21, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abuscreen ONLINE",
        "AxSYM",
        "Triage",
        "other drugs of abuse screening methods"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Quantimetrix Drug of Abuse Urine Screen Control for monitoring performance of urine drugs of abuse screening assays",
    "Indications for Use Summary": "Intended to monitor the performance of Abuscreen ONLINE, AxSYM, Triage, and other drugs of abuse screening methods for detecting drugs in unknown urine specimens",
    "fda_folder": "Toxicology"
}